NRXS
Neuraxis, INC
NASDAQ · Healthcare · Biotechnology · US
$6.86
+4.26%Price chart
Oct 6Oct 9Oct 14Oct 19Oct 22Oct 27Oct 30Nov 4
Key dataNov 4, 2026
Open$6.71
From 52W high−22.13%
Volume98247.00
Market cap$86.15M
P/E (TTM)—
P/S (TTM)16.2x
Div yield—
Key dataNov 4, 2026
Open
$6.71
From 52W high
−22.13%
Volume
98247.00
Market cap
$86.15M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−10.4x
P/E (TTM)
—
RSI (14)
41.2
MomentumView details →
1D Return
+4.26%
YTD Return
+46.26%
SummaryUpdated Jun 1, 2026
NeurAxis, Inc. (NASDAQ:NRXS) is a specialized medical device company founded in 2011 and headquartered in Carmel, Indiana. Originally incorporated as Innovative Health Solutions, Inc., the company rebranded to NeurAxis in March 2022 and went public in August 2023. NeurAxis focuses on developing and commercializing neuromodulation therapy devices, primarily targeting pediatric gastrointestinal disorders through its proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology.
Similar companies
Latest newsMore news →
Neuraxis, INC announced a medical policy coverage milestone that adds coverage for PENFS for 26 million people, bringing its national coverage footprint to more than 147 million covered lives.20d agoNeurAxis, Inc. appointed Craig Blanchard as its Chief Commercial Officer.36d agoNeurAxis announced that a major national health insurer issued a new medical policy covering its PENFS neuromodulation therapy, expanding access to over 18 million additional covered lives.49d ago